Of importance, overexpression of miR-621, which downregulates SETDB1 and p53 activity, enhanced HCC cell radiosensitivity [100,101], while the H3K9 methylation inhibitor Mithramycin A was shown to significantly reduce HCC tumor growth [36,102,103]. The gene discussed is SETDB1; the disease is neoplasm.